Legal Representation
Attorney
Monica Riva Talley
USPTO Deadlines
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 3, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jul 3, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jun 4, 2025 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Jun 4, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Mar 26, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 26, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Dec 26, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Dec 26, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Dec 26, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Apr 3, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 2, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 2, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 2, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 5, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 26, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 29, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 29, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 29, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 31, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 31, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 11, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 25, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 23, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 30, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 4, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products, namely, modified antibodies and modified derivatives of antibodies that promote an immune response, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
First Use Anywhere:
Dec 4, 2024
First Use in Commerce:
Dec 4, 2024
Classification
International Classes
005